Stocks / NASDAQ / ImmunoGen, Inc.

ImmunoGen, Inc.

Our Opinion

ImmunoGen, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“In preclinical studies, ImmunoGen has shown the eradication of colorectal, pancreatic and certain non-small-cell tumors in animal models.” Read the following document

Company Description

ImmunoGen, Inc. is a biotechnology company, which develops novel anticancer therapeutics using its antibody-drug conjugate technology. Its product candidates include Mirvetuximab Soravtansine, Coltuximab ravtansine and Kadcyla . The company was founded in March 1981 and is headquartered in Waltham, MA. [Source: MarketWatch]

Company Website: